INVITATION TO THE MEDIA & ANALYST CONFERENCE February 27, 2026, 11:00 am Results 2025 and outlook Steinhausen, February 6, 2026 – We cordially invite you to the media, analyst and investor conference of Schweiter Technologies. In addition to information on the 2025 results, we are pleased to give you an outlook for 2026. The media conference will take place on February 27, 2026 at 11:00 a.m. CET at the Hotel Marriott, Neumühlequai 42, in Zurich and will simultaneously be transmitted in a webcast: https://ww ...

Rexel: Statement relating to the total number of shares and voting rights pursuant to Article L.233-8 II of the French Commercial Code and Article 223-16 of the General Rules of the French Autorité des marchés financiers DateNumber of sharesNumber of voting rights2026-01-31296,096,004Theoretical number of voting rights(1): 296,096,004Exercisable number of voting rights(2): 293,291,344 (1) Number of voting rights including treasury shares deprived from voting rights.(2) Number of voting rights excluding trea ...

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Mereo BioPharma Group plc (NASDAQ: MREO) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Mereo securities between June 5, 2023 and December 26, 2025, both ...

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing global research sites including Cambridge, Massachusetts, and Basel, SwitzerlandApproximately 466,000-square-foot site with AI-enabled discovery capabilities, expected to house about 1,000 employees Part of a USD 23 billion US investment to expand R&D and advanced manufacturing to reach more patients East Hanover, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global B ...

LOS ANGELES, Feb. 06, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oracle Corporation (“Oracle” or “the Company”) (NYSE: ORCL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between June 12, 2025 and December 16, 2025, inclusive (the “Class Period”) ...

Ondo Finance President Ian De Bode joins Jennifer Sanasie and Andy Baehr on CoinDesk Live at the Ondo Summit to discuss the firm's ascent to more than $2 billion in TVL and its roadmap for 2026. De Bode explains how Ondo is moving beyond simple asset issuance to build a comprehensive on-chain prime brokerage. A key pillar of this strategy is the launch of Ondo Perps, a platform that allows users to trade perpetual futures on equities and commodities using their tokenized spot assets as collateral. By bridg ...

Company Performance - GE Vernova's shares increased by 98.7% in 2025 and have gained an additional 13% in 2026 so far [1] - The company reported orders worth $59 billion in 2025, with a backlog growth of $31 billion to reach $150 billion [6] - Revenue grew by 9% to $38 billion, and free cash flow (FCF) was $3.7 billion, ending the year with nearly $9 billion in cash [6] Strategic Developments - GE Vernova acquired its remaining 50% stake in Prolec GE for $5.3 billion, enhancing its position in the North American grid infrastructure market [7] - The company secured a deal with Duke Energy to supply up to 11 natural gas turbines, highlighting its role in meeting the power demands of data centers [4][5] Future Projections - For 2026, GE Vernova anticipates revenue growth of at least 15%, projecting revenues between $44 billion and $45 billion, with FCF expected to be between $5 billion and $5.5 billion [8] - By 2028, the company expects revenue to reach $56 billion and cumulative FCF to total $24 billion [8]

This could be the start of a new golden age or a tax on the American Dream for average citizens. ...

For comments and feedback contact: editorial@rttnews.com Pulse Biosciences said the first-in-human feasibility study treated 150 patients with rapid procedure times and minimal adverse effects. The data were presented at the 31st Annual AF Symposium 2026 in Boston. The stock is trading within its 52-week range of $12.56 to $22.75. Pulse Biosciences, Inc. (PLSE) shares soared 40.91 percent, gaining $5.60, to $19.29 on Friday, possibly after yesterday company released late-breaking clinical data showing succe ...

Key Takeaways REG's Q4 NAREIT FFO of $1.17 per share met estimates, rising 7.3% Y/Y on an 8.5% jump in revenues.REG delivered 4.7% same-property NOI growth, with base rent growth contributing 4.1% in the quarter.REG leased 1.7 million sq ft at a 12% blended rent spread, while same-property occupancy stood at 96.5%.Regency Centers Corporation (REG) reported fourth-quarter 2025 NAREIT funds from operations (FFO) per share of $1.17, in line with the Zacks Consensus Estimate. The figure increased 7.3% from the ...